Access cutting-edge diabetic kidney disease treatment through this clinical trial at a research site in Spokane. Study-provided care at no cost to qualified participants.
Access diabetic kidney disease specialists in Spokane at no cost
This study follows strict safety protocols and ethical guidelines
All study-related diabetic kidney disease treatment provided free
The primary objective of this study is to determine the effects of semaglutide on kidney oxygenation and function in type 1 diabetes. The secondary objective is to determine the glycemic effects and safety of semaglutide in type 1 diabetes.
Sponsor: University of Washington
Check if you qualify for this diabetic kidney disease clinical trial in Spokane, WA
If you're searching for diabetic kidney disease treatment options in Spokane, WA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Spokane research site is actively enrolling participants for this clinical trial. You'll receive care from experienced diabetic kidney disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.